AARD
AardvarkยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AARD Profile
Aardvark Therapeutics, Inc.
A biopharmaceutical company dedicated to developing drugs for weight loss and metabolic disease treatment
Pharmaceutical
05/17/2017
02/13/2025
NASDAQ Stock Exchange
22
12-31
Common stock
4370 La Jolla Village Drive, Suite 1050, San Diego, CA 92122
--
Aardvark Therapeutics, Inc., was incorporated in Delaware on May 17, 2017. The Company is a clinical-stage biopharmaceutical company focused on developing novel small molecule therapies to activate innate homeostasis pathways for the treatment of metabolic diseases. The company is targeting biological pathways associated with hunger relief that the company believes have the potential to deliver transformative outcomes for patients. The company has focused its efforts on developing selective compounds, bitter taste receptors for hunger-related conditions.
